Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Zosano Pharma (ZSAN)

Zosano Pharma (ZSAN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,614
  • Shares Outstanding, K 54,338
  • Annual Sales, $ 0 K
  • Annual Income, $ -37,590 K
  • 60-Month Beta 2.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.40
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.35
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/12/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.79
  • Growth Rate Est. (year over year) +126,555.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4050 +38.77%
on 03/16/20
1.2862 -56.31%
on 03/04/20
-0.1670 (-22.91%)
since 02/28/20
3-Month
0.4050 +38.77%
on 03/16/20
1.8034 -68.84%
on 01/07/20
-0.8080 (-58.98%)
since 12/27/19
52-Week
0.4050 +38.77%
on 03/16/20
5.4600 -89.71%
on 04/08/19
-4.2080 (-88.22%)
since 03/29/19

Most Recent Stories

More News
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2019 Financial Results

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year ended December 31, 2019, as well as recent business...

ZSAN : 0.5620 (+3.12%)
Zosano Pharma Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market

Zosano Pharma Corporation (Nasdaq:ZSAN) ("Zosano"), a clinical-stage biopharmaceutical company, today announced that it has closed its previously-announced registered direct offering priced at-the-market...

ZSAN : 0.5620 (+3.12%)
Zosano Pharma Announces $11 Million Registered Direct Offering Priced At-the-Market

Zosano Pharma Corporation (Nasdaq:ZSAN) ("Zosano"), a clinical-stage biopharmaceutical company, today announced that it has entered into definitive agreements with institutional investors for the issuance...

ZSAN : 0.5620 (+3.12%)
Zosano Pharma Announces FDA Acceptance of 505(b)(2) New Drug Application for Qtrypta(TM) for the Acute Treatment of Migraine

Zosano Pharma Corporation (Nasdaq: ZSAN), a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for Qtrypta(TM)...

ZSAN : 0.5620 (+3.12%)
Zosano Pharma Announces Pricing of $8.0 Million Public Offering of Common Stock and Warrants

Zosano Pharma Corporation (Nasdaq:ZSAN) (the "Company" or "Zosano"), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of...

ZSAN : 0.5620 (+3.12%)
Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants

Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it is commencing an underwritten public offering of units consisting of shares of common stock...

ZSAN : 0.5620 (+3.12%)
Zosano Announces FDA Submission of New Drug Application for Qtrypta

Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the submission of a 505(b)(2) New Drug Application ("NDA") for Qtrypta(TM) to the U.S. Food and Drug...

ZSAN : 0.5620 (+3.12%)
Zosano Announces Pricing of Registered Direct Offering

Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has entered into a securities purchase agreement with several institutional investors providing...

ZSAN : 0.5620 (+3.12%)
Zosano Pharma Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter ended September 30, 2019, as well as recent business highlights....

ZSAN : 0.5620 (+3.12%)
Zosano Pharma Announces Completion of Pre-NDA Meetings with FDA for Qtrypta(TM)

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has received minutes from pre- New Drug Application ("NDA") meetings with the Food and Drug...

ZSAN : 0.5620 (+3.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ZSAN with:

Business Summary

Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company's lead product candidates include Weekly ZP-PTH for severe...

See More

Key Turning Points

2nd Resistance Point 0.6200
1st Resistance Point 0.5910
Last Price 0.5620
1st Support Level 0.5390
2nd Support Level 0.5160

See More

52-Week High 5.4600
Fibonacci 61.8% 3.5290
Fibonacci 50% 2.9325
Fibonacci 38.2% 2.3360
Last Price 0.5620
52-Week Low 0.4050

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar